Enhancer Sequence Variants and Transcription-Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B-Cell Lymphoma

Immunity

Volumn 42, Issue 1, 2015, Pages 186-198

  Koues, Olivia I ^a   Kowalewski, Rodney A ^a   Chang, Li Wei ^a   Pyfrom, Sarah C ^a   Schmidt, Jennifer A ^a   Luo, Hong ^a   Sandoval, Luis E ^a   Hughes, Tyler B ^a   Bednarski, Jeffrey J ^a   Cashen, Amanda F ^a   Payton, Jacqueline E ^a   Oltz, Eugene M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CONTROLLED STUDY; ENHANCER REGION; EPIGENETICS; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SOMATIC MUTATION; ADULT; AGED; B LYMPHOCYTE; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PHYSIOLOGY; REGULATORY SEQUENCE;

ADULT; AGED; B-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GERMINAL CENTER; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MUTATION; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS;

EID: 84921320758     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.12.021     Document Type: Article

References (52)

1. Akhtar-Zaidi B., Cowper-Sal-lari R., Corradin O., Saiakhova A., Bartels C.F., Balasubramanian D., Myeroff L., Lutterbaugh J., Jarrar A., Kalady M.F., et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012, 336:736-739.
2. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
3. Allen C.D.C., Okada T., Cyster J.G. Germinal-center organization and cellular dynamics. Immunity 2007, 27:190-202.
4. Archer M.C. Role of sp transcription factors in the regulation of cancer cell metabolism. Genes Cancer 2011, 2:712-719.
5. Argiropoulos B., Humphries R.K. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007, 26:6766-6776.
6. Basu S., Liu Q., Qiu Y., Dong F. Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc. Natl. Acad. Sci. USA 2009, 106:1433-1438.
7. Baylin S.B., Jones P.A. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 2011, 11:726-734.
8. Bermudez O., Pagès G., Gimond C. The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am. J. Physiol. Cell Physiol. 2010, 299:C189-C202.
9. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. ENCODE Project Consortium.
10. Caron G., Le Gallou S., Lamy T., Tarte K., Fest T. CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells. J.Immunol. 2009, 182:7595-7602.
11. Chapuy B., McKeown M.R., Lin C.Y., Monti S., Roemer M.G.M., Qi J., Rahl P.B., Sun H.H., Yeda K.T., Doench J.G., et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 2013, 24:777-790.
12. Cheung K.-J.J., Shah S.P., Steidl C., Johnson N., Relander T., Telenius A., Lai B., Murphy K.P., Lam W., Al-Tourah A.J., et al. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood 2009, 113:137-148.
13. Compagno M., Lim W.K., Grunn A., Nandula S.V., Brahmachary M., Shen Q., Bertoni F., Ponzoni M., Scandurra M., Califano A., et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009, 459:717-721.
14. Corradin O., Saiakhova A., Akhtar-Zaidi B., Myeroff L., Willis J., Cowper-Sal lari R., Lupien M., Markowitz S., Scacheri P.C. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 2014, 24:1-13.
15. Dave S.S., Wright G., Tan B., Rosenwald A., Gascoyne R.D., Chan W.C., Fisher R.I., Braziel R.M., Rimsza L.M., Grogan T.M., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N.Engl. J. Med. 2004, 351:2159-2169.
16. Dölken G., Illerhaus G., Hirt C., Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J.Clin. Oncol. 1996, 14:1333-1344.
17. Gerstein M.B., Kundaje A., Hariharan M., Landt S.G., Yan K.-K., Cheng C., Mu X.J., Khurana E., Rozowsky J., Alexander R., et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012, 489:91-100.
18. Giresi P.G., Lieb J.D. Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). Methods 2009, 48:233-239.
19. Hagman J., Lukin K. Transcription factors drive B cell development. Curr. Opin. Immunol. 2006, 18:127-134.
20. Hnisz D., Abraham B.J., Lee T.I., Lau A., Saint-André V., Sigova A.A., Hoke H.A., Young R.A. Super-enhancers in the control of cell identity and disease. Cell 2013, 155:934-947.
21. Huang C., Geng H., Boss I., Wang L., Melnick A. Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation. Blood 2014, 123:1012-1020.
22. Ikushima H., Negishi H., Taniguchi T. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb. Symp. Quant. Biol. 2013, 78:105-116.
23. Izutsu K. Treatment of follicular lymphoma. J.Clin. Exp. Hematop. 2014, 54:31-37.
24. Kandoth C., McLellan M.D., Vandin F., Ye K., Niu B., Lu C., Xie M., Zhang Q., McMichael J.F., Wyczalkowski M.A., et al. Mutational landscape and significance across 12 major cancer types. Nature 2013, 502:333-339.
25. Khodabakhshi A.H., Morin R.D., Fejes A.P., Mungall A.J., Mungall K.L., Bolger-Munro M., Johnson N.A., Connors J.M., Gascoyne R.D., Marra M.A., et al. Recurrent targets of aberrant somatic hypermutation in lymphoma. Oncotarget 2012, 3:1308-1319.
26. Khurana E., Fu Y., Colonna V., Mu X.J., Kang H.M., Lappalainen T., Sboner A., Lochovsky L., Chen J., Harmanci A., et al. Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics. Science 2013, 342:1235587.
27. Klein U., Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 2008, 8:22-33.
28. Koues O.I., Dudley R.K., Truax A.D., Gerhardt D., Bhat K.P., McNeal S., Greer S.F. Regulation of acetylation at the major histocompatibility complex class II proximal promoter by the 19S proteasomal ATPase Sug1. Mol. Cell. Biol. 2008, 28:5837-5850.
29. Leich E., Ott G., Rosenwald A. Pathology, pathogenesis and molecular genetics of follicular NHL. Best Pract. Res. Clin. Haematol. 2011, 24:95-109.
30. Lenz G., Staudt L.M. Aggressive lymphomas. N.Engl. J. Med. 2010, 362:1417-1429.
31. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25:2078-2079. 1000 Genome Project Data Processing Subgroup.
32. Longo N.S., Lugar P.L., Yavuz S., Zhang W., Krijger P.H.L., Russ D.E., Jima D.D., Dave S.S., Grammer A.C., Lipsky P.E. Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting. Blood 2009, 113:3706-3715.
33. Masters J.R. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell Biol. 2000, 1:233-236.
34. Matys V., Kel-Margoulis O.V., Fricke E., Liebich I., Land S., Barre-Dirrie A., Reuter I., Chekmenev D., Krull M., Hornischer K., et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 2006, 34:D108-D110.
35. Maurano M.T., Humbert R., Rynes E., Thurman R.E., Haugen E., Wang H., Reynolds A.P., Sandstrom R., Qu H., Brody J., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
36. Morin R.D., Mendez-Lago M., Mungall A.J., Goya R., Mungall K.L., Corbett R.D., Johnson N.A., Severson T.M., Chiu R., Field M., et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011, 476:298-303.
37. Neph S., Vierstra J., Stergachis A.B., Reynolds A.P., Haugen E., Vernot B., Thurman R.E., John S., Sandstrom R., Johnson A.K., et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012, 489:83-90.
38. Pasqualucci L., Khiabanian H., Fangazio M., Vasishtha M., Messina M., Holmes A.B., Ouillette P., Trifonov V., Rossi D., Tabbò F., et al. Genetics of follicular lymphoma transformation. Cell Rep. 2014, 6:130-140.
39. Rehm A., Mensen A., Schradi K., Gerlach K., Wittstock S., Winter S., Büchner G., Dörken B., Lipp M., Höpken U.E. Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs. Blood 2011, 118:1020-1033.
40. Rui L., Schmitz R., Ceribelli M., Staudt L.M. Malignant pirates of the immune system. Nat. Immunol. 2011, 12:933-940.
41. Sanyal A., Lajoie B.R., Jain G., Dekker J. The long-range interaction landscape of gene promoters. Nature 2012, 489:109-113.
42. Shah N., Sukumar S. The Hox genes and their roles in oncogenesis. Nat. Rev. Cancer 2010, 10:361-371.
43. Slager S.L., Rabe K.G., Achenbach S.J., Vachon C.M., Goldin L.R., Strom S.S., Lanasa M.C., Spector L.G., Rassenti L.Z., Leis J.F., et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 2011, 117:1911-1916.
44. Tarte K., De Vos J., Thykjaer T., Zhan F., Fiol G., Costes V., Rème T., Legouffe E., Rossi J.-F., Shaughnessy J., et al. Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood 2002, 100:1113-1122.
45. Thurman R.E., Rynes E., Humbert R., Vierstra J., Maurano M.T., Haugen E., Sheffield N.C., Stergachis A.B., Wang H., Vernot B., et al. The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82.
46. Trapnell C., Roberts A., Goff L., Pertea G., Kim D., Kelley D.R., Pimentel H., Salzberg S.L., Rinn J.L., Pachter L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7:562-578.
47. Urayama K.Y., Thompson P.D., Taylor M., Trachtenberg E.A., Chokkalingam A.P. Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence. Front Oncol 2013, 3:300.
48. Victora G.D., Nussenzweig M.C. Germinal centers. Annu. Rev. Immunol. 2012, 30:429-457.
49. Victora G.D., Dominguez-Sola D., Holmes A.B., Deroubaix S., Dalla-Favera R., Nussenzweig M.C. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 2012, 120:2240-2248.
50. Wang H., Morse H.C. IRF8 regulates myeloid and B lymphoid lineage diversification. Immunol. Res. 2009, 43:109-117.
51. Whyte W.A., Orlando D.A., Hnisz D., Abraham B.J., Lin C.Y., Kagey M.H., Rahl P.B., Lee T.I., Young R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
52. Yap D.B., Chu J., Berg T., Schapira M., Cheng S.-W.G., Moradian A., Morin R.D., Mungall A.J., Meissner B., Boyle M., et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 2011, 117:2451-2459.